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Background: While the lifetime risk of developing cervical cancer (CaCx) and acquiring HIV is high for women in
Tanzania, most women have not tested for HIV in the past year and most have never been screened for CaCx.
Good management of both diseases, which have a synergistic relationship, requires integrated screening,
prevention, and treatment services. The aim of this analysis is to assess the acceptability, feasibility and effectiveness
of integrating HIV testing into CaCx prevention services in Tanzania, so as to inform scale-up strategies.
Methods: We analysed 2010 – 2013 service delivery data from 21 government health facilities in four regions of
the country, to examine integration of HIV testing within newly introduced CaCx screening and treatment services,
located in the reproductive and child health (RCH) section of the facility. Analysis included the proportion of clients
offered and accepting the HIV test, reasons why testing was not offered or was declined, and HIV status of CaCx
screening clients.
Results: A total of 24,966 women were screened for CaCx; of these, approximately one-quarter (26%) were referred
in from HIV care and treatment clinics. Among the women of unknown HIV status (n = 18,539), 60% were offered
an HIV test. The proportion of women offered an HIV test varied over time, but showed a trend of decline as the
program expanded. Unavailability of HIV test kits at the facility was the most common reason for a CaCx screening
client not to be offered an HIV test (71% of 6,321 cases). Almost all women offered (94%) accepted testing, and 5%
of those tested (582 women) learned for the first time that they were HIV-positive.
Conclusion: Integrating HIV testing into CaCx screening services was highly acceptable to clients and was an
effective means of reaching HIV-positive women who did not know their status; effectiveness was limited, however,
by shortages of HIV test kits at facilities. Integration of HIV testing into CaCx screening services should be prioritized
in HIV-endemic settings, but more work is needed to eliminate logistical barriers. The coverage of CaCx screening
among HIV care and treatment-enrolled women in Tanzania may be low and should be examined.
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Tanzanian women face a dual burden of disease: rates of
both cervical cancer and HIV/AIDS are high. Cervical
cancer (CaCx) is the most common and deadly cancer
among women; each year, over 7,300 Tanzanian women
are diagnosed with the disease and more than half die [1].
The age-adjusted incidence rate of cervical cancer in
Tanzania is among the highest in the world at 54 deaths
per 100,000 women, compared with 42.7 across Eastern
Africa and 14 worldwide [1]. HIV/AIDS is also among the
leading causes of death for women in Tanzania, with HIV
prevalence estimated at 6.2% among women age 15–49 [2].
Screening programs for cervical cancer and HIV can
save lives when linked with appropriate treatment.
Inspecting the cervix after applying a dilute solution of
acetic acid allows for the visualization, identification,
and immediate treatment of precancerous lesions with
cryotherapy, which has an 86% to 95% cure rate for eli-
gible lesions [3]. In developing countries, a one-time
screening at around age 35 has been shown to reduce a
women’s lifetime risk of cervical cancer by 25% to 36% [4].
Similarly, providing anti-retroviral therapy to people in-
fected with HIV has been shown to increase life expect-
ancy by 11 years in South Africa, while reducing HIV
transmission [5]. Treating HIV with anti-retroviral therapy
also reduces mortality due to cervical cancer, according to
modelling based on a cohort in Cameroon [6].
To achieve a significant public health impact, cervical
cancer and HIV screening must be implemented on a wide
scale [7-9], but this has proven difficult to achieve in many
developing countries. While estimates vary [10,11], a 2008
analysis of population-based surveys in 57 countries found
that 19% of women in developing countries, on average,
had been screened for cervical cancer in the preceding
three years. Although Tanzania was not included in this
analysis, neighbouring countries such as Malawi, Kenya
and Zambia had among the lowest screening rates, with
more than 90% of women reporting that they had never
had a pelvic exam [12]. HIV testing also remains far from
universal among Tanzanian women. While the proportion
of women who reported ever being tested for HIV in-
creased from 37% in 2007 [13] to 62% in 2011 [2], only
30% of women surveyed in 2011 reported that they had
been tested in the last 12 months and had received the test
results.
Integrating health services is a proven strategy for im-
proving quality of care and increasing uptake of services.
It is particularly relevant to cervical cancer and HIV/
AIDS, because both are sexually transmitted and infection
with one increases vulnerability to the other [14]. HIV-
positive women are at greater risk of infection with human
papilloma virus (HPV), the main cause of invasive cervical
cancer [15,16], and HIV infection is associated with
greater prevalence and persistence of HPV, high-risk HPVsubtypes, and higher HPV viral load [17,18]. Likewise,
women with HPV are more vulnerable to HIV infection,
as seen in a study in Zimbabwe which noted a 2.4 times
greater risk of acquiring HIV infection among women
with cervical HPV infection [19].
Dozens of countries have adopted integrated approaches
to expand HIV testing coverage, instructing providers to
routinely offer HIV tests to patients seeking antenatal,
family planning, outpatient, or other services [20-24]. The
Tanzanian Ministry of Health and Social Welfare
(MOHSW) integrated this type of provider-initiated HIV
testing and counselling (PITC) into routine health service
delivery in 2007 [25]. While numerous implementation
challenges have been noted, PITC has succeeded in in-
creasing the number of people tested for HIV and identify-
ing previously undiagnosed cases [22,26,27]. The success
of PITC in antenatal care—including in Tanzania—sug-
gests that integrating PITC into cervical cancer screening
could be a successful approach to increasing uptake of
HIV testing among women, with the goal of initiating
HIV care and treatment at an earlier stage. Documented
results, however, are scarce. The cervical cancer preven-
tion program in Zambia, for example, has adopted PITC,
but has not yet published results in peer-reviewed litera-
ture [20].
Until recently in Tanzania, testing for cervical cancer
was limited to just two tertiary-level facilities and was only
available to women with suspected cancer. In 2010 the
MOHSW announced a National Strategy for Cervical
Cancer Prevention [28] that recommends a low-cost ap-
proach proven to be highly effective in developing coun-
tries: visual inspection with acetic acid (VIA) to screen
women, followed by immediate cryotherapy or referral for
loop electrosurgical excision procedure (LEEP) when pre-
cancerous lesions are found [29-32]. In the National Strat-
egy, the MOHSW recommends that VIA screening and
cryotherapy be offered primarily at Reproductive and
Child Health (RCH) clinics and that PITC be integrated
into cervical cancer screening. The recommendation of
the MOHSW was based on a priority to offer cervical can-
cer screening to all women, regardless of HIV status. In
contrast, most other Sub-Saharan African countries that
have integrated cervical cancer and HIV services have lo-
cated VIA screening in HIV care and treatment clinics and
prioritized HIV-positive women for screening [30,33-35].
To assess the acceptability of the integration of HIV
testing into cervical cancer screening and treatment
services, we conducted a secondary analysis on routine
service delivery data from selected government health
facilities in Tanzania implementing CaCx screening and
treatment services. These facilities offered CaCx screening
using VIA, cryotherapy for eligible clients, referral for
women with large lesions or suspect cancer, and offered
HIV testing as part of the service. Three of the facilities
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fered LEEP for treatment of large lesions.
The objective of this analysis was to provide a rough
measure of the success of integration of HIV testing into
cervical cancer screening, in order to inform scale-up of
cervical cancer screening services in Tanzania. In this ana-
lysis, we considered acceptance of the HIV test by clients
to be a measure of acceptability, and number and propor-
tion of women being offered the HIV test to be a measure
of effectiveness. Key questions examined included: did
CaCx screening clients accept HIV testing when offered?
Did the integration of HIV testing result in significantly
expanded uptake of HIV testing among eligible women?
Did the integration result in identifying previously undiag-
nosed cases of HIV? How consistently has the HIV testing
service been offered as part of CaCx screening in these
facilities from 2010 to 2013?
Methods
Description of the integration model
The Cervical Cancer Prevention (CECAP) program rolled
out services by facility in a staggered fashion, beginning in
2010. Facilities were grouped together for training, and at
least three health care providers from each facility were
trained using a nationally-approved 6 day training on VIA
screening and cryotherapy. Among the 75 providers
trained, all had already been trained in PITC and were
providing HIV testing: 14 providers (19%) worked at HIV
Care and Treatment Centres (CTCs) and 7 (9%) were
working in multiple departments of the facility, including
HIV CTC, outpatient department (OPD) and/or RCH. In
addition, all providers working in the onsite HIV CTCs at
these facilities received a one day orientation to CaCx
screening, emphasizing the importance of referral for
HIV-infected women.
CaCx screening and HIV testing are always provided on
the same visit and in the same location. Most facilities
described offer CaCx screening in the RCH clinic at least
twice a week, but not every day. Family planning (FP) ser-
vices are offered through the RCH, and are available every
day that CaCx screening is offered, and while the service
is not integrated (meaning that FP is not routinely offered
to every CaCx screening client) the service is at least
conveniently co-located. Following national policy, HIV
testing is offered to all women unless they are HIV posi-
tive or (self ) report being tested in the last three months.
In Tanzania, the date and results of an HIV test are re-
corded anonymously in a register, not in individual client
records. Therefore, providers do not have a recorded
means to share information about HIV testing of a client,
and must rely on client’s self report. If a client is reactive
to an HIV test administered at the CaCx screening, she is
referred to the onsite HIV CTC. Women referred in from
the HIV CTC are instructed to show their CTC enrolmentcard to the provider at the CaCx screening in the RCH.
The provider then proceeds with screening without offer-
ing an HIV test and notes some of the client’s information,
including HIV status, available CD4 counts and whether
or not the woman is on antiretroviral therapy, on the
CaCx individual client record.
Sample
This analysis includes routine client level service delivery
data from a convenience sample of 21 government health
facilities, all of which offered VIA and same-day cryother-
apy at the RCH clinic and also had an onsite HIV CTC.
All were supported by a United States Government
(USG)-funded program to improve maternal, newborn,
and reproductive health care services in Tanzania called
Mothers and Infants, Safe Healthy and Alive (MAISHA).
The 21 facilities are located in four of Tanzania’s 30 re-
gions (Morogoro, Iringa, and Njombe regions and Dar es
Salaam municipality). The facility sample included the na-
tional consultant referral hospital, two regional hospitals,
twelve district hospitals, and six health centres.
In three facilities in this sample, CaCx screening and
treatment service was launched before the MOHSW
adopted the integration of PITC into the service. This ana-
lysis is restricted to the time period in which these facil-
ities had integrated PITC into the CaCx screening service.
Data collection
Health care providers record clinical information related
to the CaCx service on a nationally-approved individual
client record at the time of service. ‘Reason a client was
not offered an HIV test’ and ‘reason for declining a test’
are fields on this record. Client-level data is available in
a client-level database from MAISHA facilities which is
maintained by an implementing partner on behalf of the
MOHSW; this CaCx prevention program (CECAP) data-
base holds individual client records, stripped of all identi-
fying information. Client records do not leave the health
facility and are directly entered by a program-based data
manager on site. An aggregated database is housed at the
MOHSW to monitor national results on CaCx screening
services, however, the aggregated database does not cap-
ture responses to the above variables.
Results presented in this paper are drawn from new
client records in the CECAP database from August 2010
to September 2013. All new client records within these
dates were included in the analysis (no records were
excluded). Returning clients were not included in this
analysis and will be examined in a separate analysis.
Mean months services of service were drawn from the
database and cross-checked with program reports. Infor-
mation on health care providers, such as dates trained,
demographic information, and cadre were drawn from
program training records.
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Frequencies were run on client level data exported from
the CECAP database into Excel and SPSS (version 22).
We calculated the percentage of eligible clients who were
offered an HIV test, the percentage of women who
accepted that offer, and the percentage of women who
tested positive for HIV. We also analysed the reasons why
eligible clients were not offered or refused an HIV test.
Ethical considerations
A non-research determination was obtained from John
Hopkins University Institutional Review Board (IRB) for
secondary analysis of the de-identified CECAP client
dataset. The analysis was performed under the guidance
of the MOHSW.
Results
Characteristics of CECAP providers and clients
A total of 75 providers were trained to offer VIA screen-
ing and cryotherapy at the 21 facilities described, from
Morogoro, Njombe, Iringa regions and Muhimbili National
Referral Hospital in Dar es Salaam. The majority were
nurses (71%), and the remainder were physicians (21%), as-
sistant medical officers (7%) and medical attendants (1%).
In 18 of the 21 facilities, at least one of the providers
trained was stationed at the HIV CTC, or was the medical
officer in charge of the HIV CTC. All of the other pro-
viders trained were stationed in the RCH clinic (Table 1).
On average, 21 months of service delivery records are
included for each facility, and the months of data ana-
lysed ranged from 4 to 38 (Table 2). A total of 24,966
women were screened for cervical cancer for the first
time at these 21 facilities. The mean age of the women
screened was 37.6 years (range 17–88), and mean parity
was 3.5 (range 0–16).
The total number of women screened for CaCx in-
creased each quarter as additional facilities introduced
the screening service. Peaks occurred around training
events, when women were actively recruited to ensure
that providers had sufficient practice. The number of
women screened monthly at each facility ranged from 25
to 411.Table 1 Health care providers trained in VIA and cryotherapy
Region Number of providers t









Total 56HIV status and testing
Of the 24,966 clients screened for cervical cancer, 26%
(6,427) were referred from the HIV CTC and were not of-
fered an HIV test when they came for CaCx screening.
The proportion of clients referred from the HIV CTC var-
ied considerably between regions, ranging from 18% to
36% (Table 1). The remaining 18,539 clients were of un-
known HIV status. Of these, 60% were offered an HIV test
and accepted. Providers did not offer an HIV test to 4,490
women due to stock outs of HIV test kits or reagent. An-
other 1,786 women were not offered an HIV test because
they self-reported an HIV test within the previous three
months (Figure 1).
Almost all (94%) of the 11,819 clients who were offered
an HIV test accepted it. Five percent of those testing (582
women) were diagnosed as being HIV infected. Of the
747 women who declined the offer of an HIV test, most
(96%) said they ‘did not feel ready’ or ‘were afraid.’ Three
percent said they wanted to consult their husband, while
the remaining 1% did not specify a reason.
The proportion of CaCx screening clients offered an
HIV test each quarter varied widely over time, ranging
from 16% to 96%. The proportion of clients offered HIV
testing started out high, averaging 86% across all facil-
ities in 2011, and fell to 62% in 2012 and 55% in 2013
(Figure 2). From January 2012 onwards, the effects of
major, national scale shortages of HIV test kits became
apparent in CaCx services. For example, in April 2012,
the number of CaCx screening clients not offered an
HIV test almost quadrupled.
Discussion
This analysis shows that the model used in Tanzania for
integrating HIV testing into cervical cancer prevention
services holds great promise. The approach was widely
accepted by both providers and clients; providers consist-
ently offered HIV tests when test kits were available; and
women almost universally agreed to HIV testing when
offered. This finding is consistent with other studies that
show high rates of acceptance of HIV testing as part of
integrated services [23,31,32]. The program reached a
large number of women, identified cases of HIV amongand their station in the facility
rained in VIA and cryotherapy from: Total









Table 2 Health facilities and clients included in the analysis, by region, August 2010 – September 2013
Region Number of
health facilities
Mean number of months
CaCx screening and treatment
services were offered (range)
Women screened for cervical cancer
Total number Percent distribution by HIV status*
Positive Unknown
Morogoro 9 29 (6– 38) 12,292 18% 82%
Iringa 6 17 (5 – 30) 5,661 35% 65%
Njombe 5 13 (6 – 19) 5,369 36% 64%
Dar es Salaam 1 4 1,644 21% 79%
Total 21 21 (4 – 38) 24,966 26% 74%
*HIV-positive includes women who presented a CTC enrolment card. All other women were regarded as unknown HIV status (figures on those women testing
positive are presented in Figure 1).
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and linked these women with HIV care and treatment.
The biggest challenge affecting the effectiveness of inte-
gration was insufficient supply of HIV test kits at the
health facilities providing the service. Scaling up HIV test-
ing as part CaCx screening will require additional fore-
casting, ordering, distribution, and quality monitoring of
test kits [23]. In Tanzania, the government-run Medical
Stores Department (MSD) manages procurement and
logistics of HIV test kits for public health facilities, and
notable challenges in supply chain management have been
described.
Beginning in December 2011, there was a major disrup-
tion of the supply chain for HIV test kits in Tanzania after
the first-line HIV test was discontinued due to quality
control issues. Throughout 2012 and early 2013, the sup-
ply of HIV test kits remained erratic while the MOHSW
established a new algorithm, secured the necessary test
kits, retrained providers, and began shipping new kits to
facilities through regional medical stores [33]. Service de-
livery data show that this disruption caused a precipitous
drop in PITC. According to anecdotal reports, the impact























Figure 1 Coverage and results of HIV testing among CaCx screeningtheir stocks of test kits ran out; as supplies of test kits
dwindled, health care providers often prioritized pregnant
women to facilitate prevention of mother-to-child trans-
mission of HIV.
Although not covered in this analysis, observations from
program implementers suggest that a shortage of health
care providers in these facilities contributed to both lower
than expected number of women screened for CaCx, as
well as lower coverage of HIV testing within the service.
Like other countries in sub-Saharan Africa, Tanzania suf-
fers from a severe shortage of health care providers; only
40% of the health care professionals needed for adequate
coverage of health services are actually employed [34].
The rapid scale up of HIV/AIDS testing, care, and treat-
ment has increased demand for providers, led to heavier
workloads, eroded morale, and contributed to burnout
[35]. According to anecdotal reports, providers consist-
ently complained about overwork (although they did not
specifically point to PITC as the cause). While some HIV-
related services in the Tanzanian health system are associ-
ated with financial incentives, such as overtime pay, CaCx
screening services are not. Declining morale among pro-






























PITC offered PITC not offered
Figure 2 CaCx screening clients with unknown HIV status who were and were not offered PITC, August 2010 – September 2013.
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plain the low numbers of women screened for CaCx in
Tanzania. None of these challenges are unique to Tanzania.
In Zimbabwe, a recent study blamed shortages of trained
staff, counselling space, and HIV test kits for hampering
implementation of PITC [24].
If integrated CaCx and HIV services are to be scaled up
nationwide, the CECAP program in Tanzania must ensure
that facilities are accurately forecasting demand and order-
ing sufficient HIV test kits to assure supplies at facilities.
The national procurement and commodity logistics systems
of MSD for HIV test kits must be improved. Additionally,
as PITC is brought to scale, women tested for HIV
throughout the health facility—not just those enrolled at
HIV CTCs—should be referred for CaCx screening. The
program must also find a way to address gaps in the work-
force, whether through training, task shifting, and/or efforts
to improve retention [10].
Ideally, the integration of CaCx and HIV services should
flow in two directions. On the one hand, women coming
for CaCx screening should be offered HIV tests and refer-
rals for care and treatment if found positive, and case
management of clients with CaCx or pre-cancer should
take into consideration the women’s HIV status. On the
other hand, all women enrolled in HIV care and treatmentshould be accessing CaCx screening services, due to their
elevated risk of CaCx and need for screening at a younger
age. This analysis only examined the first type of integra-
tion: that of HIV testing into the CaCx service. Program
data suggest, however, that integration in the other direc-
tion was not as effective: in these same facilities, the pro-
portion of women enrolled in HIV CTCs who were
screened for CaCx ranged from almost none (3%) to less
than half (46%) during the April 2010 to March 2012 time
period [36]. For a more comprehensive assessment of
HIV/ CECAP service integration, further investigation is
needed into CaCx screening coverage among women en-
rolled in HIV CTCs.
Strengths and limitations
This secondary analysis demonstrates the potential of
working with routinely collected service delivery data, es-
pecially when steps have been taken to strengthen the
health information management system. In this case, it
allowed us to assess measures of feasibility and effective-
ness of integrating HIV testing into CaCx services in the
absence of a formal evaluation. Although analysis was
conducted by MAISHA program, which led the program,
the calculations presented in this paper were done by indi-
viduals who had limited connection to the clinical service.
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level is subject to the normal errors inherent in a manual
system in an understaffed health care setting, the MAISHA
program led quality improvement measures focusing on
providers’ recording of information into client records.
This means that the data taken from the individual client
records was of somewhat higher quality than typical manu-
ally recorded health information data. Data on clients’
reasons for declining an HIV test may have additional con-
straints because it was solicited and recorded by providers,
which may have introduced bias into responses.
Conclusions
The MOHSW’s CECAP program in Tanzania has piloted
systematic integration of HIV testing in CaCx prevention
and treatment. The approach has proven to be highly ac-
ceptable, both to providers and to women, and an effective
way to identify women who do not know they are HIV-
infected and refer them to appropriate care and treatment.
Countries with a high HIV prevalence, like Tanzania,
should prioritize the integration of PITC into CaCx pre-
vention services. Failing to do so will result in a less com-
prehensive CECAP service, higher costs to clients in terms
of illness and mortality, and potentially, higher costs to the
health care system for treatment rather than prevention.
Successfully implementing this strategy requires recogniz-
ing and overcoming commodity supply challenges.
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